1
|
Zhou Y, Zhou Z, Chan D, Chung PY, Wang Y, Chan ASC, Law S, Lam KH, Tang JCO. The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican. Int J Mol Sci 2022; 23:13181. [PMID: 36361971 PMCID: PMC9655098 DOI: 10.3390/ijms232113181] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Revised: 10/26/2022] [Accepted: 10/26/2022] [Indexed: 07/30/2023] Open
Abstract
Quinoline derivatives have been reported to possess a wide range of pharmaceutical activities. Our group previously synthesized a series of quinoline compounds, in which compound 91b1 showed a significant anticancer effect. The purpose of this study was to evaluate the anticancer activity of compound 91b1 in vitro and in vivo, and screen out its regulated target. A series of cancer cell lines and nontumor cell lines were treated with compound 91b1 by MTS cytotoxicity assay and cell-cycle assay. In vivo anticancer activity was evaluated by a xenografted model on nude mice. Target prediction of 91b1 was assessed by microarray assay and confirmed by pancancer analysis. Relative expression of the target gene Lumican was measured by qRT-PCR. 91b1 significantly reduced tumor size in the nude mice xenograft model. Lumican was downregulated after 91b1 treatment. Lumican was proven to increase tumorigenesis in vivo, as well as cancer cell migration, invasion, and proliferation in vitro. The results of this study suggest that the anticancer activity of compound 91b1 probably works through downregulating the gene Lumican.
Collapse
Affiliation(s)
- Yuanyuan Zhou
- School of Biomedical Engineering, Sun Yat-sen University, Guangzhou 510006, China
- State Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China
| | - Zhongguo Zhou
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4032, Australia
| | - Dessy Chan
- State Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China
| | - Po yee Chung
- State Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China
| | - Yongqi Wang
- Department of Biosystems Science and Eng, Eidgenössische Technische Hochschule (ETH) Zürich, 4058 Basel, Switzerland
| | - Albert Sun chi Chan
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
| | - Simon Law
- Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
| | - Kim hung Lam
- State Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China
| | - Johnny Cheuk On Tang
- State Key Laboratory of Chemical Biology and Drug Discovery, Lo Ka Chung Centre for Natural Anticancer Drug, Development, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China
| |
Collapse
|
2
|
Chen TL, Patel AS, Jain V, Kuppusamy R, Lin YW, Hou MH, Su TL, Lee TC. Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[ g]pyrrolo[2,1- a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links. J Med Chem 2021; 64:12469-12486. [PMID: 34459195 DOI: 10.1021/acs.jmedchem.0c01733] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Designing hybrid molecules with dual functions is one approach to improve the therapeutic efficacy of combination treatment. We have previously conjugated phthalazine and bis(hydroxymethyl)pyrrole pharmacophores to form hybrids bearing antiangiogenesis and DNA interstrand cross-linking activities. To improve the bioavailability, we adopted a benzology approach to design and synthesize a new series of 1,2-bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazines. These new hybrids retained the dual functions and could be formulated into vehicles for intravenous and oral administration. Among them, we demonstrated that compound 19a with dimethylamine at the C6 position markedly suppressed the tumor growth of human small cell lung cancer cell line H526, squamous lung cancer cell line H520, and renal cancer cell line 786-O in nude mice, implying that compound 19a is a broad-spectrum anticancer agent. Our results implicated that the conjugation of antiangiogenic and DNA cross-linking is likely to be a helpful approach to improving the efficacy of combination therapy.
Collapse
Affiliation(s)
- Tai-Lin Chen
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.,School of Pharmacy, China Medical University, Taichung 40400, Taiwan
| | - Anilkumar S Patel
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.,Department of Chemistry, Atmiya University, Rajkot 360005, Gujarat, India
| | - Vicky Jain
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.,Department of Chemistry, Marwadi University, Rajkot 360003, Gujarat, India
| | | | - Yi-Wen Lin
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
| | - Ming-Hon Hou
- Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 40227, Taiwan
| | - Tsann-Long Su
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
| | - Te-Chang Lee
- Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
| |
Collapse
|
3
|
Li HT, Zhu X. Quinoline-based Compounds with Potential Activity against Drugresistant Cancers. Curr Top Med Chem 2021; 21:426-437. [PMID: 32552650 DOI: 10.2174/1568026620666200618113957] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2020] [Revised: 05/06/2020] [Accepted: 05/12/2020] [Indexed: 11/22/2022]
Abstract
Drug resistance is the major cause of the failure of cancer chemotherapy, so one of the most important features in developing effective cancer therapeutic strategies is to overcome drug resistance. Quinoline moiety has become one of the most privileged structural motifs in anticancer agent discovery since its derivatives possess potent activity against various cancers including drug-resistant cancers. Several quinoline-based compounds which are represented by Anlotinib, Bosutinib, Lenvatinib, and Neratinib have already been applied in clinical practice to fight against cancers, so quinoline-based compounds are potential anticancer agents. The present short review article provides an overview of the recent advances of quinoline-based compounds with potential activity against drug-resistant cancers. The structure-activity relationship and mechanisms of action are also discussed.
Collapse
Affiliation(s)
- Huan-Ting Li
- Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, 014040, China
| | - Xiaoyong Zhu
- Department of Oncology, Zhuji Affiliated Hospital of Shaoxing University, Zhejiang Province 311800, China
| |
Collapse
|
4
|
Yadav P, Shah K. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry. Bioorg Chem 2021; 109:104639. [PMID: 33618829 DOI: 10.1016/j.bioorg.2021.104639] [Citation(s) in RCA: 65] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 01/04/2021] [Accepted: 01/04/2021] [Indexed: 02/06/2023]
Abstract
Quinoline is a versatile pharmacophore, a privileged scaffold and an outstanding fused heterocyclic compound with a wide range of pharmacological prospective such as anticancer, anti-inflammatory, antibacterial, antiviral drug and superlative moiety in drug discovery. The quinoline hybrids have already been shown excellent results with new targets with a different mode of actions as an inhibitor of cell proliferation by cell cycle arrest, apoptosis, angiogenesis, disruption of cell migration and modulation. This review emphasized the mode of action, structure activity relationship and molecular docking to reveal the various active pharmacophores of quinoline hybrids accountable for novel anticancer, anti-inflammatory, antibacterial and miscellaneous activities. Therefore, several quinoline candidates are under clinical trials for the treatment of certain diseases, for example ferroquine (antimalarial), dactolisib (antitumor) and pelitinib (EGFR TK inhibitors) etc. Plenty of research has been summarized the recent advances of quinoline derivatives and explore the various therapeutic prospects of this moiety. This review would help the researchers to strategically design diverse novel quinoline derivatives for the development of clinically viable drug candidates for the treatment of incurable diseases.
Collapse
Affiliation(s)
- Pratibha Yadav
- Institute of Pharmaceutical Research, GLA University, Mathura, UP 281406, India
| | - Kamal Shah
- Institute of Pharmaceutical Research, GLA University, Mathura, UP 281406, India.
| |
Collapse
|
5
|
Liu C, Tian X, Su C, Huang J, Chu X, Deng S, Cheng K. Synthesis and cytotoxicity of pentacyclic triterpenes‐aniline nitrogen mustard derivatives. J CHIN CHEM SOC-TAIP 2020. [DOI: 10.1002/jccs.201900049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Chun‐Mei Liu
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Xiao‐Yan Tian
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Chun‐Hua Su
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Jia‐Yan Huang
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Xiang‐Wu Chu
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Sheng‐Ping Deng
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| | - Ke‐Guang Cheng
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and PharmacyGuangxi Normal University Guilin P. R. China
| |
Collapse
|
6
|
Zheng Y, Gan H, Zhao Y, Li W, Wu Y, Yan X, Wang Y, Li J, Li J, Wang X. Self‐Assembly and Antitumor Activity of a Polyoxovanadate‐Based Coordination Nanocage. Chemistry 2019; 25:15326-15332. [DOI: 10.1002/chem.201903333] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 09/13/2019] [Indexed: 12/15/2022]
Affiliation(s)
- Yan Zheng
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
- Department of GeriatricsFirst Hospital of Jilin University Changchun Jilin 130021 P.R. China
| | - Hongmei Gan
- Department of ChemistryNortheast Normal University 5268 Renmin Street, Changchun Jilin 130024 P.R. China
| | - Yao Zhao
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Wanling Li
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Yuchen Wu
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Xuechun Yan
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Yifan Wang
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Jinhua Li
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Juan Li
- School of Public HealthJilin University, 1163 Xinmin Street, Changchun Jilin 130021 P.R. China
| | - Xinlong Wang
- Department of ChemistryNortheast Normal University 5268 Renmin Street, Changchun Jilin 130024 P.R. China
| |
Collapse
|